The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics

Cell physiology is regulated along the 24-h time scale by a circadian timing system composed of molecular clocks within each cell and a central coordination system in the brain. The mammalian molecular clock is made of interconnected molecular loops involving at least 12 circadian genes. The cellular clocks are coordinated by the suprachiasmatic nucleus, a hypothalamic pacemaker which also helps the organism adjust to environmental cycles. The rest-activity rhythm is a reliable marker of the circadian system function in both rodents and Man. It can be monitored non-invasively through several devices or systems. The circadian organization is responsible for predictable changes in the tolerability and efficacy of anticancer agents, and also controls tumor promotion and growth. The clinical relevance of the chronotherapy principle, i.e. treatment administration as a function of rhythms, has been demonstrated in randomized multicenter trials,using programmable-in-time drug delivery systems. Chronotherapeutic schedules first documented the safety and the activity of oxaliplatin-based combination chemotherapy inpatients with metastatic colorectal cancer. The chronotherapy concept offers further promises for improving current cancer treatment options as well as for optimizing the development of new anticancer or supportive agents. Technological developments of chronotherapeutics in daily practice are essential in order to non invasively assess dynamic changes in biological functions and to insure temporally-adjusted therapeutics interventions.

[1]  S. Yamaguchi,et al.  Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo , 2003, Science.

[2]  P. Vrignaud,et al.  Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination. , 2001, Cancer research.

[3]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[4]  F. Lévi,et al.  Tumor-based rhythms of anticancer efficacy in experimental models , 2002, Chronobiology international.

[5]  Christopher R. Jones,et al.  An hPer2 Phosphorylation Site Mutation in Familial Advanced Sleep Phase Syndrome , 2001, Science.

[6]  F. Lévi,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[7]  P. Vrignaud,et al.  Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma , 2002, British Journal of Cancer.

[8]  J. Lellouch,et al.  Marked 24h Rest / Activity Rhythms Are Associated with Better Quality of Life , Better Response , and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status 1 , 2000 .

[9]  F. Lévi,et al.  Effects of light and food schedules on liver and tumor molecular clocks , 2007 .

[10]  R. Smaaland,et al.  Circadian Stage Dependent Variation of Cortisol Related to DNA Synthesis in Human Bone Marrow , 1991 .

[11]  Stefano Iacobelli,et al.  Effects of light and food schedules on liver and tumor molecular clocks in mice. , 2005, Journal of the National Cancer Institute.

[12]  Francis Lévi,et al.  Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.

[13]  O D Laerum,et al.  DNA synthesis in human bone marrow is circadian stage dependent. , 1991, Blood.

[14]  F. Lévi.  Circadian Rhythms in 5-Fluorouracil Pharmacology and Therapeutic Applications , 2003 .

[15]  A. Reinberg,et al.  Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice. , 1989, Cancer research.

[16]  Giuseppe Tonini,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[17]  Paolo Sassone-Corsi,et al.  A Web of Circadian Pacemakers , 2002, Cell.

[18]  A. B. Reddy,et al.  A clockwork web: circadian timing in brain and periphery, in health and disease , 2003, Nature Reviews Neuroscience.

[19]  R. Jordan,et al.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium. , 1999, The American journal of pathology.

[20]  Francis Lévi,et al.  Chronotherapeutics: The Relevance of Timing in Cancer Therapy , 2006, Cancer Causes & Control.

[21]  Paolo Sassone-Corsi,et al.  Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.